Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) groupSuzana Jordan, Thierry Zénone, Jörg H. W. Distler et al.|Annals of the Rheumatic Diseases|2014Cited by 432
Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohortCarina Mihai, Dorota Krasowska, Oliver Distler et al.|Lara D. Veeken|2019Cited by 29
Title Page / Table of ContentsThilo Hackert, on behalf of the Dutch Pancreatitis Study Group, Michael Camilleri et al.|Digestive Diseases|2016Cited by 0